Search Within

MSK Grad Students

  1. "Dermatology Service"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (14)
  3. Correspondence (3)
  4. Review (3)
  5. Editorial (2)
  6. Miscellaneous (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (45)
  2. Dermatology (45)
  3. Dermatology Service (45)
  4. Division of Subspecialty Medicine (45)
  5. CTCR Scholars (38)
  6. Master of Science in Clinical and Translational Cancer Research (38)

More Groups

People
  1. Edmund Bartlett (19)
  2. Michael Marchetti (19)
  3. Alina Markova (16)
  4. Doris Ponce (15)
  5. Stephen Dusza (13)
  6. Daniel Coit (9)

More People

Years
  1. 2024 (5)
  2. 2023 (7)
  3. 2022 (11)
  4. 2021 (6)
  5. 2020 (7)
  6. 2019 (5)

More Years

Publications
  1. Journal of the American Academy of Dermatology (8)
  2. Blood (6)
  3. JAMA Dermatology (5)
  4. Transplantation and Cellular Therapy (5)
  5. Annals of Surgical Oncology (4)
  6. Journal of the American College of Surgeons (4)

More Publications

Publishers
  1. Elsevier Inc. (8)
  2. Mosby Elsevier (8)
  3. American Society of Hematology (6)
  4. American Medical Association (5)
  5. Elsevier Science, Inc. (5)
  6. Springer (5)

More Publishers

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cost-benefit implication of gene expression profiling and adjuvant therapy in stage IIIA melanoma
    Journal Article

    Hu, Y.; Briggs, A.; Marchetti, M. A.; Ariyan, C. E.; Coit, D. G.; Bartlett, E. K.
    Journal of the American College of Surgeons (2020)

    Fulltext@MSK | Save
  • Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma
    Correspondence

    Marchetti, M. A.; Dusza, S. W.; Bartlett, E. K.
    Journal of the American Academy of Dermatology (2020)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitors to treat cutaneous malignancies
    Miscellaneous

    Barrios, D. M.; Do, M. H.; Phillips, G. S.; Postow, M. A.; Akaike, T.; Nghiem, P.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2020)

    Fulltext@MSK | Save
  • Gene expression profile-based risk modeling to select patients with melanoma who can avoid sentinel lymph node biopsy: Are we there yet?
    Correspondence

    Bartlett, E. K.; Marchetti, M. A.; Coit, D. G.
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Prognostic gene expression profiling in cutaneous melanoma: Identifying the knowledge gaps and assessing the clinical benefit
    Review

    Grossman, D.; Okwundu, N.; Bartlett, E. K.; Marchetti, M. A.; Othus, M.; Coit, D. G.; Hartman, R. I.; Leachman, S. A.; Berry, E. G.; Korde, L.; more...
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • Performance of gene expression profile tests for prognosis in patients with localized cutaneous melanoma: A systematic review and meta-analysis
    Journal Article

    Marchetti, M. A.; Coit, D. G.; Dusza, S. W.; Yu, A.; McLean, L.; Hu, Y.; Nanda, J. K.; Matsoukas, K.; Mancebo, S. E.; Bartlett, E. K.
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • Photobiomodulation (PBM) provides a prompt and near-resolution response to advanced oral chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
    Meeting Abstract

    Ponce, D. M.; Markova, A.; Moore, G.; Dahi, P. B.; Papadopoulos, E. B.; Tamari, R.; Giralt, S. A.; Prockop, S. E.; Barash, A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • HLA-a*0101 allele is associated with increased risk of cutaneous acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Fonseca, M.; Jakubowski, A. A.; Devlin, S. M.; Young, J. W.; Fatmi, S.; Maloy, M. A.; Giralt, S. A.; Ponce, D. M.; Markova, A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Inpatient management of mucocutaneous GVHD
    Review

    Vaidya, T. S.; Menzer, C.; Ponce, D. M.; Markova, A.
    Current Dermatology Reports (2019)

    Fulltext@MSK | Save
  • Cost-effectiveness of adjuvant therapy for stage IIIA melanoma is poor even when patients are risk-stratified by gene expression profile
    Meeting Abstract

    Hu, Y.; Briggs, A.; Marchetti, M.; Coit, D.; Bartlett, E.
    Journal of the American College of Surgeons (2019)

    Fulltext@MSK | Save